Dr Reddy#39;s continues to recall Levetiracetam Injection from US market

According to a letter written to the US Food and Drug Administration on Februray 4, the drug maker said the recall, which began in October 2018, was originally initiated due to a product complaint received for mislabelling.

from Moneycontrol Business News http://bit.ly/2DUyOOi